LOS ANGELES–(BUSINESS WIRE)–Dr. Rohit Varma of the CHA HPMC Southern California Eye Institute has published the largest eye study on Chinese Americans to date.
Author: Business Wire
Washington DC Ophthalmology Practice Enters Strategic Partnership With Eyecare Services Partners and Eye Doctors of Washington
DALLAS–(BUSINESS WIRE)–Howard Jacobson, MD (Jacobson), a highly respected ophthalmic practice in Washington D.C., has entered into a strategic partnership with an affiliate of Eyecare Services Partners Management, LLC (“ESP”), the leading national pr…
ObjectiveEd Joins Microsoft’s AI for Accessibility Program
BOSTON–(BUSINESS WIRE)–ObjectiveEd joins Microsoft’s AI for Accessibility program to further its efforts in maximizing educational outcomes for children with disabilities.
Le choix intelligent en recherche clinique précoce
PHILADELPHIE–(BUSINESS WIRE)–À l’occasion du congrès Clinical Trials Phase I & II A qui s’ouvre aujourd’hui à Philadelphie, le partenariat sans but lucratif CATALIS Québec dévoile une campagne promotionnelle pour faire connaître les atouts du Qué…
The smart choice in early-stage clinical research
PHILADELPHIA–(BUSINESS WIRE)– #ClinicalTrialsQuebec–CATALIS Quebec Clinical Trials demonstrate Quebec’s expertise in early-phase clinical trials. Discover the possibilities: clinicaltrialsquebec.com
Compulink Showcases AI-Powered, All-in-One Orthopaedic EHR Solution at ASES 2019
NEWBURY PARK, Calif.–(BUSINESS WIRE)–Compulink showcases AI-powered, all-in-one orthopaedic EHR solution at ASES 2019.
Dry Eye Disease (DED) in EU5 (Germany, Spain, Italy, France, UK): Epidemiology Analysis & Forecast 2017-2028 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Dry Eye Disease (DED) – Epidemiology Forecast to 2028” report has been added to ResearchAndMarkets.com’s offering. This report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of …
Aura Biosciences Announces Updated Phase 1b/2 Clinical Data for AU-011 Presented at the American Academy of Ophthalmology 2019 Annual Meeting
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences, a leader in the development of novel targeted therapies in ocular oncology, today announced the presentation of updated clinical data from its ongoing Phase 1b/2 clinical trial evaluating the safety …
Craig Johnson Has Joined Visioneering Technologies Inc. as Quality Specialist
ATLANTA–(BUSINESS WIRE)–Craig Johnson joined Visioneering Technologies, Inc. in the role of Quality Specialist, based in their Alpharetta, GA Headquarters. Johnson will be responsible for ongoing management of field quality activities including mater…
Lineage Cell Therapeutics Presents New OpRegen® Data at American Academy of Ophthalmology Annual Meeting
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #AMD–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, today announced positive additional result…
テジ・コーリ財団、角膜失明を世界中からなくすための拡大可能で利用しやすく廉価なテクノロジー・ソリューションを提唱
ロンドン–(BUSINESS WIRE)–（ビジネスワイヤ） — テジ・コーリ財団は世界視力デーにあたり、治療可能な角膜失明を世界中からなくすという世界的使命の達成を加速するには新しい技術に集中する必要があるとの意見を表明しました。当財団は現在、角膜失明に関して利用しやすく拡大可能で廉価な「生合成液」ソリューションの臨床試験と開発に資金提供しています。これは、この種の失明を患っている世界中の1200万人の患者の多くにとって意味を持つものです。 テジ・コーリ財団では、世界各地の人道的活動をAI、…
Avellino Labs Receives CLIA Certification for Its AvaGen Genetic Diagnostic Test for Keratoconus and Corneal Dystrophies
MENLO PARK, Calif.–(BUSINESS WIRE)–Avellino Labs receives CLIA certification for AvaGen genetic diagnostic for keratoconus and corneal dystrophies.
Williamson Eye Center Becomes Preferred Ophthalmology Provider for Baton Rouge General
BATON ROUGE, La.–(BUSINESS WIRE)– #eyecare–The Williamson Eye Center has formed a strategic partnership with the Baton Rouge General Medical Center by opening a fifth location on Summa Avenue.
Sun Pharma Launches CEQUA for the Treatment of Dry Eye Disease in the U.S.
MUMBAI, India & PRINCETON, N.J.–(BUSINESS WIRE)– #Cequa–Sun Pharma Launches CEQUA for the Treatment of Dry Eye Disease in the U.S.
Topcon Healthcare Selected to Ease Transition for IBM® Merge Eye Station and Merge Eye Care PACS Customers
OAKLAND, N.J.–(BUSINESS WIRE)– #AAO–Topcon Healthcare Selected to Ease Transition for IBM Watson Health Imaging Merge Eye Station and Merge Eye Care PACS Customers
New Data from Teprotumumab Phase 3 OPTIC Study Shows Significantly Reduced Double Vision and Improved Quality of Life for People with Active Thyroid Eye Disease
DUBLIN–(BUSINESS WIRE)–New data from Phase 3 teprotumumab study shows significant benefit on several devastating effects of active thyroid eye disease (TED).
Eyevensys présente les premiers résultats de son étude clinique de phase I / II évaluant une thérapie génique non virale innovante pour les maladies oculaires au 11e Sommet Annuel de l'Innovation en Ophtalmologie
SAN FRANCISCO–(BUSINESS WIRE)–Eyevensys, société privée de biotechnologie au stade clinique développant des thérapies géniques non virales pour les maladies oculaires, a présenté cette semaine les résultats de la première partie de son étude de phase…
Eyevensys Presents Initial Data from Phase I/II Trial of Innovative, Non-Viral Gene Therapy for Ocular Diseases at 11th Annual Ophthalmology Innovation Summit
SAN FRANCISCO–(BUSINESS WIRE)– #OIS2019–Eyevensys presented initial results from a phase I/II trial of its innovative, non-viral gene therapy for ocular diseases at OIS@AAO this week.
Global Ophthalmic Lens Market 2019-2023| Evolving Opportunities with Bausch Health & Essilor|Technavio
LONDON–(BUSINESS WIRE)– #Healthcare–The global ophthalmic lens market size is poised to grow by USD 13.15 billion during 2019-2023, according to a new report by Technavio.
Tej Kohli基金會宣導一種可擴展、易取得且平價的技術解決方案來終結全球角膜失明
倫敦–(BUSINESS WIRE)–(美國商業資訊)–在世界視力日，Tej Kohli基金會表示，必須專注於新技術，才能加快在全世界終結可治癒角膜失明的全球使命。基金會目前正在資助臨床試驗和一種液態生物合成(liquid biosynthetic)解決方案的開發，該解決方案可望提供易於取得、可擴展且平價的角膜失明解決方案，這種解決方案對於全世界1200萬角膜失明患者中的許多人是極為重要的。 Tej Kohli基金會的論點是，人工智慧、機器人和基因體學等指數級成長的技術將大幅促進全世界的人道主…